Cargando…

Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia

Mycoplasmapneumoniae is one of the major causative pathogens of community-acquired pneumonia (CAP). M. pneumoniae CAP is clinically and radiologically distinct from bacterial CAPs. One feature of the Japanese Respiratory Society (JRS) guidelines is a trial to be carried out to differentiate between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyashita, Naoyuki, Nakamori, Yasushi, Ogata, Makoto, Fukuda, Naoki, Yamura, Akihisa, Ishiura, Yoshihisa, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878343/ https://www.ncbi.nlm.nih.gov/pubmed/35207236 http://dx.doi.org/10.3390/jcm11040964

Ejemplares similares

Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19
por: Miyashita, Naoyuki, et al.
Publicado: (2023)

Clinical features of nursing and healthcare-associated pneumonia due to COVID-19
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

A warning related to predicting the severity of COVID-19 pneumonia using the A-DROP scoring system
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Prognosis of activities of daily living function in hospitalized patients with nursing and healthcare‐associated pneumonia due to COVID‐19
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Functional outcomes in elderly patients with hospitalized COVID‐19 pneumonia: A 1 year follow‐up study
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections
por: Miyashita, Naoyuki, et al.
Publicado: (2023)

Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia
por: Tang, Mingyu, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ)
por: von Baum, Heike, et al.
Publicado: (2009)

Transient Acquired Hemophilia Associated with Mycoplasma Pneumoniae Pneumonia
por: Kim, Min Sun, et al.
Publicado: (2008)

Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
por: Li, Fei, et al.
Publicado: (2022)

Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing
por: Miyashita, Naoyuki, et al.
Publicado: (2009)

A preliminary study on the potential of Mycoplasma pneumoniae to induce dyskaryotic change in respiratory epithelium in adult community-acquired pneumonia
por: An, Shu-Chang, et al.
Publicado: (2016)

Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
por: Dumke, Roger, et al.
Publicado: (2015)

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy
por: Loconsole, Daniela, et al.
Publicado: (2019)

Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia
por: Zhao, Meng-chuan, et al.
Publicado: (2019)

Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia
por: Jiang, Wujun, et al.
Publicado: (2013)

Retrospective survey for sialidase activity in Mycoplasma pneumoniae isolates from cases of community-acquired pneumonia
por: May, Meghan, et al.
Publicado: (2011)

Molecular detection of Mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia
por: Chaudhry, Rama, et al.
Publicado: (2013)

Clinical spectrum and diagnostic yields of Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia
por: Dash, Saroj, et al.
Publicado: (2018)

Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia
por: Copete, Angela Rocio, et al.
Publicado: (2018)

A study of community-acquired Mycoplasma pneumoniae in Yantai, China
por: Yu, Hong-Xia, et al.
Publicado: (2018)

Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
por: Yang, Beilei, et al.
Publicado: (2021)

Peculiar Cold-Induced Leukoagglutination in Mycoplasma pneumoniae Pneumonia
por: Kubota, Yasushi, et al.
Publicado: (2017)

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States
por: Diaz, Maureen H., et al.
Publicado: (2015)

Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis
por: Medjo, Biljana, et al.
Publicado: (2014)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
por: Merida-Vieyra, Jocelin, et al.
Publicado: (2019)

Community-Acquired Pneumonia Caused by Mycoplasma pneumoniae: How Physical and Radiological Examination Contribute to Successful Diagnosis
por: Kishaba, Tomoo
Publicado: (2016)

Mycoplasma pneumoniae pneumonia in children
por: Youn, You-Sook, et al.
Publicado: (2012)

The History of Mycoplasma pneumoniae Pneumonia
por: Saraya, Takeshi
Publicado: (2016)

Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays
por: Ishimaru, Naoto, et al.
Publicado: (2021)

Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia
por: Youn, You-Sook, et al.
Publicado: (2010)

Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children
por: Meyer Sauteur, Patrick M, et al.
Publicado: (2019)

Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China
por: Cao, B., et al.
Publicado: (2010)

Impact of COVID-19 on the Epidemiological Features of Mycoplasma pneumoniae Infection in Children with Community-Acquired Pneumonia in Henan, China
por: Li, Lifeng, et al.
Publicado: (2023)

The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: A meta-analysis
por: Gong, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4s5srmj3fd7bpqgtcd4fo5nm03